Trial Details

Not Recruiting
Basic Information
Clinical ID c3136
Identifier NL-OMON27672
Trial Title Adjusting infliximab dose in IBD patients in remission, based on infliximab trough levels: the study on Infliximab Levels in IBD patients Steering Treatment, the ILIST pilot
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Inflammatory Bowel Disease, in remission with infliximab treatment.
Interventions IFX trough levels are measured in IBD patients in long term remission. Based on IFX trough levels, the IFX dose may be adjusted. The IFX dosing interval does not change. If IFX trough levels are high ( If IFX trough levels are normal (0.3 g/mL), the IFX dose remains stable.
Participant Information
Sponsor Erasmus MC Rotterdam
City -
Country/Region -
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -